Bahl & Gaynor Inc Zimmer Biomet Holdings, Inc. Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q2 2024

A detailed history of Bahl & Gaynor Inc transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 8,714 shares of ZBH stock, worth $940,589. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,714

Previous 8,403 3.7%

Holding current value

$940,589

Previous $1.11 Million 14.79%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$106.25 - $130.01 $33,043 - $40,433	311 Added 3.7%	8,714 $945,000
Q1 2024 May 10, 2024	BUY	$119.98 - $132.61 $5,039 - $5,569	42 Added 0.5%	8,403 $1.11 Million
Q4 2023 Feb 02, 2024	SELL	$102.72 - $121.7 $7,293 - $8,640	-71 Reduced 0.84%	8,361 $1.02 Million
Q3 2023 Nov 03, 2023	SELL	$110.76 - $143.18 $29,019 - $37,513	-262 Reduced 3.01%	8,432 $946,000
Q2 2023 Aug 14, 2023	SELL	$126.43 - $145.6 $2,022 - $2,329	-16 Reduced 0.18%	8,694 $1.27 Million
Q1 2023 May 03, 2023	SELL	$121.91 - $130.94 $2,194 - $2,356	-18 Reduced 0.21%	8,710 $1.13 Million
Q4 2022 Feb 10, 2023	SELL	$104.7 - $128.4 $34,236 - $41,986	-327 Reduced 3.61%	8,728 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$101.65 - $119.27 $71,459 - $83,846	-703 Reduced 7.2%	9,055 $947,000
Q2 2022 Aug 08, 2022	BUY	$102.23 - $133.85 $1,431 - $1,873	14 Added 0.14%	9,758 $1.03 Million
Q1 2022 May 12, 2022	SELL	$108.42 - $129.58 $71,557 - $85,522	-660 Reduced 6.34%	9,744 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$136.35 - $158.76 $38,178 - $44,452	-280 Reduced 2.62%	10,404 $1.52 Million
Q1 2021 May 11, 2021	SELL	$148.16 - $159.71 $3,704 - $3,992	-25 Reduced 0.23%	10,684 $1.71 Million
Q4 2020 Feb 02, 2021	BUY	$128.25 - $151.41 $46,170 - $54,507	360 Added 3.48%	10,709 $1.65 Million
Q3 2020 Nov 12, 2020	SELL	$113.59 - $141.68 $68,154 - $85,008	-600 Reduced 5.48%	10,349 $1.41 Million
Q2 2020 Aug 13, 2020	SELL	$87.02 - $133.4 $47,425 - $72,703	-545 Reduced 4.74%	10,949 $1.31 Million
Q1 2020 May 26, 2020	BUY	$78.28 - $155.73 $899,750 - $1.79 Million	11,494 New	11,494 $1.16 Million
Q1 2020 May 15, 2020	SELL	$78.28 - $155.73 $925,113 - $1.84 Million	-11,818 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$127.4 - $146.83 $9,555 - $11,012	-75 Reduced 0.63%	11,818 $1.77 Million
Q3 2019 Nov 14, 2019	BUY	$113.33 - $138.46 $15,866 - $19,384	140 Added 1.19%	11,893 $1.63 Million
Q2 2019 Aug 12, 2019	BUY	$108.87 - $125.09 $11,975 - $13,759	110 Added 0.94%	11,753 $1.38 Million
Q4 2018 Feb 12, 2019	SELL	$94.4 - $126.76 $30,208 - $40,563	-320 Reduced 2.67%	11,643 $1.21 Million
Q3 2018 Nov 09, 2018	SELL	$108.41 - $127.64 $20,489 - $24,123	-189 Reduced 1.56%	11,963 $1.57 Million
Q2 2018 Aug 14, 2018	SELL	$102.12 - $114.04 $1.22 Million - $1.36 Million	-11,963 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$106.92 - $117.79 $40,095 - $44,171	-375 Reduced 3.04%	11,963 $1.4 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-236 Reduced 1.88%	12,338 $1.58 Million
Q2 2017 Aug 10, 2017	BUY	N/A	12,574	12,574 $1.3 Million

Others Institutions Holding ZBH

# of Institutions

1,094

Shares Held

185M

Call Options Held

313K

Put Options Held

475K

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.6B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account